RxDoctor Payments Data

Alan Tesson, MD

Sleep Medicine · Fairfax, VANPI 1902063662

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,919 of the $2,436 with a category attached, or 78.8%. Inspire Medical Systems, Inc. accounts for 83.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $1,894 and has fallen 92.1% since, to $149 in 2025.

$2,436in general payments, 2019–2025

Across 20 payments — averaging $121.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$2K
  • Teva Pharmaceuticals USA, Inc.$168
  • Avadel CNS Pharmaceuticals, LLC$103
  • Harmony Biosciences LLC$40
  • AbbVie$37
  • Resmed Corp$22
  • plus $22 from 1 others

What the payments were for

  • Travel & lodging$51721%
  • Food & beverage$1,91979%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,436 in reported general payments places this provider in the 65th percentile of 74 sleep medicine providers in Virginia.

See all sleep medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$67,952
Medicare patients
280
Services billed
534

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NeuproRotigotine25$20,245
Modafinil33$3,995
Doxepin Hcl16$2,347
Gabapentin107$1,093
Pregabalin23$1,075
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl17$778
Memantine Hcl26$477
Pramipexole DihydrochloridePramipexole Di-Hcl30$377
Donepezil Hcl23$375
Mirtazapine22$336
Duloxetine Hcl12$284
Prazosin Hcl12$164
Sumatriptan Succinate15$146
Trazodone Hcl31$124
Clonazepam20$93

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Fairfax

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →